PACTR201902473450574

Caffeine phonophoresis versus shock wave therapy for adult females with cellulite

Caffeine phonophoresis versus shock wave therapy for adult females with cellulite: A randomized controlled trial
Faculty of physical therapy·Early Phase 1·Pan Africa Clinical Trials Registry·device·Device trialRecruiting
Study focus
Intervention type
device
Sponsor & location
Primary sponsor
Faculty of physical therapy
Funder
The authors of the article
Location
Egypt
Timeline & enrollment
Phase
Early Phase 1
Start date
Jan 27, 2019
End date
Apr 14, 2019
Summary

Caffeine phonophoresis versus shock wave therapy for adult females with cellulite: A randomized controlled trial.Background: Cellulite is a widespread problem involving females' buttocks and thighs (85% of post-adolescent women). It is characterized by an irregular, dimpled skin surface with thinning of the epidermis/dermis and presence of nodular clusters of fat cells. Caffeine has anticellulite effect due to its lipolytic activity in fatty cells. Moreover, shock wave therapy treats cellulite through improvement of cell permeability. Objective: To compare between the effects of caffeine phonophoresis and shock wave therapy in the treatment of female with cellulite.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201902473450574
Type
Device Trial
About this record

Access comprehensive clinical trial information for PACTR201902473450574 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Faculty of physical therapy and is currently Recruiting. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.